Drug Shortage Report for JAMP GEFITINIB
| Report ID | 207314 |
| Drug Identification Number | 02500663 |
| Brand name | JAMP GEFITINIB |
| Common or Proper name | Gefitinib Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GEFITINIB |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 3x10 |
| ATC code | L01EB |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-16 |
| Estimated end date | 2024-01-15 |
| Actual end date | 2024-01-31 |
| Shortage status | Resolved |
| Updated date | 2024-02-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-02-05 | French | Compare |
| v9 | 2024-02-05 | English | Compare |
| v8 | 2024-02-05 | French | Compare |
| v7 | 2024-02-05 | English | Compare |
| v6 | 2024-01-22 | French | Compare |
| v5 | 2024-01-22 | English | Compare |
| v4 | 2023-12-30 | French | Compare |
| v3 | 2023-12-30 | English | Compare |
| v2 | 2023-10-18 | French | Compare |
| v1 | 2023-10-18 | English | Compare |
Showing 1 to 10 of 10